Background: Neurofilament light chain (NfL) is a promising biomarker of neuroaxonal injury, increasingly used to monitor neurodegeneration in Alzheimer’s disease (AD). The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.